Every now and then we catch a good one. Saw the news and watched after hours. Watched pre market but hype and buzz didn't happen till later in the day? Very odd.
Press Release Source: Intellipharmaceutics International Inc. On Thursday March 11, 2010, 5:00 pm EST
TORONTO, March 11, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI - News) (TSX:I - News) today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR(R) (dexmethylphenidate hydrochloride). The terms of the settlements are confidential and remain subject to regulatory and court approval weeeeeeeeeeeeeeeee insert-text-here insert-text-here
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.